Loading the session
Loading the session
Loading instrument
$708.51
+0.33%DelayedDelayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 19:41 IST · A quote does not mean the product is available to trade on your account.
In brief
Questions investors ask
Quotes run fifteen minutes behind.
Closed at $706.16 on 4 Nov 2026: 0.8% below the 52-week high of $712.17 (4 Nov 2026) and 62.2% above the low of $435.27 (18 May 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
1 month: +7.6% (SPY −1.6%, XLK −12.6%). 3 months: +22.2% (SPY −0.4%, XLK −5.1%). 1 year: +24.9% (SPY +13.6%, XLK +20.1%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: TMO, SPY and XLK · as of 4 Nov 2026
The 4 Nov 2026 close of $706.16 was 7.2% above its 50-day average ($658.67) and 27.8% above its 200-day average ($552.49). It has closed above the 200-day for 74 sessions, since 23 Jul 2026. The 50-day average crossed above the 200-day on 18 Aug 2026, 55 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
4.9M shares were sold short at the 15 Oct 2026 settlement, 1.3% of the 370.5M shares outstanding; covering them would take 2.1 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Price return, split-adjusted
At the 4 Nov 2026 close
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
April 23, 2026
−9.20%October 1, 2025
+9.42%July 23, 2025
+9.14%